1. Home
  2. IOBT vs TELO Comparison

IOBT vs TELO Comparison

Compare IOBT & TELO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOBT
  • TELO
  • Stock Information
  • Founded
  • IOBT 2014
  • TELO 2021
  • Country
  • IOBT Denmark
  • TELO United States
  • Employees
  • IOBT N/A
  • TELO N/A
  • Industry
  • IOBT Biotechnology: Pharmaceutical Preparations
  • TELO
  • Sector
  • IOBT Health Care
  • TELO
  • Exchange
  • IOBT Nasdaq
  • TELO NYSE
  • Market Cap
  • IOBT 79.7M
  • TELO 79.2M
  • IPO Year
  • IOBT 2021
  • TELO 2024
  • Fundamental
  • Price
  • IOBT $1.60
  • TELO $2.08
  • Analyst Decision
  • IOBT Strong Buy
  • TELO
  • Analyst Count
  • IOBT 3
  • TELO 0
  • Target Price
  • IOBT $9.33
  • TELO N/A
  • AVG Volume (30 Days)
  • IOBT 147.9K
  • TELO 146.2K
  • Earning Date
  • IOBT 05-14-2025
  • TELO 05-14-2025
  • Dividend Yield
  • IOBT N/A
  • TELO N/A
  • EPS Growth
  • IOBT N/A
  • TELO N/A
  • EPS
  • IOBT N/A
  • TELO N/A
  • Revenue
  • IOBT N/A
  • TELO N/A
  • Revenue This Year
  • IOBT N/A
  • TELO N/A
  • Revenue Next Year
  • IOBT N/A
  • TELO N/A
  • P/E Ratio
  • IOBT N/A
  • TELO N/A
  • Revenue Growth
  • IOBT N/A
  • TELO N/A
  • 52 Week Low
  • IOBT $0.66
  • TELO $1.88
  • 52 Week High
  • IOBT $1.73
  • TELO $8.40
  • Technical
  • Relative Strength Index (RSI)
  • IOBT 78.81
  • TELO 35.38
  • Support Level
  • IOBT $1.09
  • TELO $1.88
  • Resistance Level
  • IOBT $1.29
  • TELO $2.19
  • Average True Range (ATR)
  • IOBT 0.12
  • TELO 0.22
  • MACD
  • IOBT 0.05
  • TELO -0.01
  • Stochastic Oscillator
  • IOBT 88.21
  • TELO 16.32

About IOBT IO Biotech Inc.

IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.

About TELO TELOMIR PHARMACEUTICALS INC

Telomir Pharmaceuticals Inc is a pioneering preclinical-stage pharmaceutical company which leads the advancement of age-reversal science. The Company is focused on developing Telomir-1, a novel small molecule designed to lengthen and protect telomeres-the protective DNA end caps of chromosomes that are crucial to cellular aging. As humans and animals age, telomeres naturally shorten, with metal reactivity accelerating this process, increasing the risk of degenerative and age-related diseases. By addressing the underlying causes of aging at the cellular level, Telomir aims to tackle the root of these conditions rather than simply treating their symptoms. Telomir is conducting ongoing preclinical research into Progeria, diabetes, cancer, Alzheimer's disease, osteoarthritis, and others.

Share on Social Networks: